SCHEMBL375313

SCHEMBL375313

CC(O)[N]C(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2000035 0.76
Isopropyl Alcohol SCHEMBL28372300 0.72
Isopropyl Alcohol SCHEMBL14797735 0.72
SCHEMBL313187 0.70
Isopropyl Alcohol SCHEMBL27983513 0.67
SCHEMBL15681481 0.67
SCHEMBL13745896 0.67
SCHEMBL5711122 0.67
SCHEMBL538180 0.67
SCHEMBL15214291 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 586 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191478-B1 COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS NOVARTIS AG (CH) 2019-05-08 EP claimed
US-20180015090-A1 COMPOUNDS FOR ENHANCING PPARy EXPRESSION AND NUCLEAR TRANSLOCATION AND THERAPEUTIC USE THEREOF REALINN LIFE SCIENCE LIMITED (TW) 2018-01-18 US claimed
EP-2368947-B1 Ink composition SEIKO EPSON CORP (JP) 2016-12-21 EP claimed
EP-2382315-B1 NUCLEIC ACID PURIFICATION METHOD QIAGEN GMBH (DE) 2015-09-23 EP claimed
EP-2447253-B1 DIHYDROPYRIMIDINE COMPOUNDS, PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR USE AS ANTIVIRAL AGENTS INST PHARM & TOXICOLOGY AMMS (CN) 2014-06-18 EP claimed
EP-2066662-B1 SERINE HYDROLASE INHIBITORS KYORIN SEIYAKU KK (JP) 2012-12-05 EP claimed
EP-2382315-A1 NUCLEIC ACID PURIFICATION METHOD Qiagen GmbH (DE) 2011-11-02 EP claimed
US-7985424-B2 Dendritic polymers with enhanced amplification and interior functionality DENDRITIC NANOTECHNOLOGIES INC. (US) 2011-07-26 US claimed
EP-2325236-A1 Dendritic polymers with enhanced amplification and interior functionality Dendritic Nanotechnologies Inc. (US) 2011-05-25 EP claimed
US-7879846-B2 e.g. 2-(2-Imidazol-1-yl-pyridin-3-yl)-5-methyl-4H-benz[d][1,3]oxazin-4-one ; neutrophil elastase inhibitor; antiinflammatory agent, respiratory system disorders Kyorin Pharmaceutical Co.., Ltd. (JP) 2011-02-01 US claimed
US-4608383-A Cardioactive pyrazole and imidazole aryloxypropanolamines BOEHRINGER MANNHEIM GMBH (DE) 1986-08-26 US claimed
EP-0187520-A2 Water-soluble dye IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-07-16 EP claimed
EP-0179549-A2 Water-soluble dye IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-04-30 EP claimed
EP-0176195-A2 Water-soluble dye IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-04-02 EP claimed
EP-0173476-A2 Water-soluble dye IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-03-05 EP claimed
EP-0011166-B1 LIQUID, COLD-STABLE DETERGENT CONCENTRATE AND ITS USE Henkel Kommanditgesellschaft auf Aktien (DE) 1982-05-05 EP claimed
US-4308014-A AN UNSATURATED ESTER OR AMIDE, A TITANIUM ALKOXIDE OR A TRIALKOXY SILANE, A FREE RADICAL CATALYST AND AN ACTIVATOR; DENTISTRY KANEBO LTD. (JP) 1981-12-29 US claimed
EP-0011166-A1 Liquid, cold-stable detergent concentrate and its use Henkel Kommanditgesellschaft auf Aktien (DE) 1980-05-28 EP claimed
US-4009158-A DYEING AND PRINTING FIBERS SANDOZ LTD. (CH) 1977-02-22 US claimed
US-4005076-A ANTIBIOTICS GRUPPO LEPETIT S.P.A. (IT) 1977-01-25 US claimed